OCARINA · CN42097
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A study investigating the pharmacokinetics, pharmacodynamics, safety, and radiological and clinical effects of subcutaneous (SC) versus intravenous (IV) ocrelizumab in patients with multiple sclerosis. EudraCT: 2020-005448-48.
Sponsor: ROCHE
Phase: III
Area: Neuroimmunology